Monitor execution pace and any subsequent financial reports for fundamental changes. The buyback may provide price support but does not alter the underlying business outlook. Watch for quarterly updates on repurchase activity.
Price Chart
Executive Summary
BioNTech announced the commencement of its previously authorized $1.0 billion share buyback program, effective June 8, 2026, through May 6, 2027. The program allows repurchase of up to 24.9 million ADSs (≈10% of share capital) via an independent credit institution, compliant with 10b-18/10b5-1 rules.
Key Facts
- $1.0 billion share buyback program authorized on May 7, 2026, with buyback period June 8, 2026 to May 6, 2027.
- Up to 24.9 million American Depositary Shares (ADSs) may be repurchased, representing approximately 10% of BioNTech's share capital.
- Buyback will be executed by an independent credit institution in compliance with EU MAR and SEC Rules 10b-18 and 10b5-1.
- Repurchased ADSs may be used for ordinary course obligations and to enhance capital efficiency.
Financial Impact
The $1.0 billion buyback represents approximately 4.5% of BioNTech's $22.1B market cap. Potential EPS accretion if fully executed, but no immediate financial impact.
Risk Factors
- Buyback may not be fully executed due to market conditions or corporate decisions.
- Underlying business fundamentals (e.g., COVID vaccine demand) could deteriorate, offsetting any buyback benefits.
- Regulatory or legal constraints could limit repurchase activity.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001776985-26-000041 |
| Document: a991june2026sbbarticle51ma.htm | 0001776985-26-000041 |
| Document: 0001776985-26-000041-index-headers.html | 0001776985-26-000041 |
| Document: 0001776985-26-000041-index.html | 0001776985-26-000041 |
| Document: 0001776985-26-000041.txt | 0001776985-26-000041 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 14, 2026 18d ago | 6-K | $98.86 $98.00 | ▼ −0.87% | ▼ −0.98% | $96.61 (−2.28%) |
Sep 14, 2026 18d ago | Press Release | $98.86 $98.00 | ▼ −0.87% | ▼ −0.98% | $96.61 (−2.28%) |
Aug 28, 2026 5w ago | 6-K | $102.08 $103.76 | ▼ −1.65% | ▼ −1.54% | $96.61 (+5.36%) |
Aug 20, 2026 6w ago | 6-K | $110.89 $111.40 | ▲ +0.46% | ▼ −0.65% | $96.61 (−12.88%) |
Aug 11, 2026 7w ago | Institutional Cluster | $92.80 $92.75 | ▼ −0.05% | ▲ +0.35% | $96.61 (+4.10%) |
Aug 4, 2026 8w ago | 6-K | $91.35 $92.80 | ▼ −1.59% | ▼ −1.69% | $96.61 (−5.75%) |
Aug 3, 2026 8w ago | 6-K | $92.25 $92.80 | ▲ +0.60% | ▼ −1.43% | $96.61 (+4.72%) |
Aug 3, 2026 8w ago | Press Release | $92.25 $92.80 | ▲ +0.60% | ▼ −1.43% | $96.61 (+4.72%) |
Jul 29, 2026 9w ago | 6-K | $92.85 $91.19 | ▼ −1.79% | ▼ −5.41% | $96.61 (+4.04%) |
Jun 8, 2026 16w ago | 6-K | $85.50 $90.80 | ▲ +6.20% | ▲ +4.09% | $96.61 (+12.99%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access